Abstract

Hemolytic uremic syndrome (HUS) developed in about 25% of individuals who were infected with Shiga toxin–producing Escherichia coli serotype O104:H4 as part of the European outbreak in 2011 (JW Infect Dis Jun 29 2011). Limited data are available about treatment options for such patients. Now, researchers report the results of plasma exchange …

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.